Last updated on February 2018

MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing

Brief description of study

The purpose of this Clinical investigation is to assess the impact of the Multi Point Pacing (MPP) feature at 12 months in the treatment of patients not responding to standard Cardiac Resynchronization Therapy (CRT) after 6 months.

Detailed Study Description

This study is designed as a prospective, randomized, multi-center trial. Data will be collected at enrollment, baseline, implant procedure, patient classification, 6 months and 12 months of follow-up. During the 6-month visit, the patient's response to CRT will be evaluated according to LVESV reduction. Patients with an LVESV reduction of at least 15% will be classified as responders. These patients will terminate their participation in the study and return to the center's standard practice. Patients with an LVESV reduction less than 15% will be classified as non-responders and the MPP feature will be activated according to randomization result and they will be followed until the 12-month visit.

Clinical Study Identifier: NCT02006069

Contact Investigators or Research Sites near you

Start Over

Rajesh Vijayvergiya, Dr.

Postgraduate Institute of Medical Education & Research
Chandigarh, India
  Connect »